Cymbio Pharma Private Limited, a active private limited company, was established on 14 September 1998 in Bangalore, Karnataka, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U85110KA1998PTC024210. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹2.50 Cr.
It upholds a compliant status. Employing 34 professional, Its leadership includes Sudarshan Karle (Director), Mahendra Karle (Director), Fiona Karle (Director). Past directors included Amrita Ajith. It holds ₹30.29 Cr open charges and ₹4.10 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at No.23/4, Venkatala Yelahanka Hobli Yelahanka, Bangalore, Karnataka, 560064.
U85110KA1998PTC024210
024210
14 September 1998
₹10.00 Cr
₹2.50 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Cymbio Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sudarshan Karle | Director | 24 May 2003 | Current |
| Mahendra Karle | Director | 24 May 2003 | Current |
| Fiona Karle | Director | 24 May 2004 | Current |
| Kyung Seon Cho | Director | 24 May 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 May 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cymbio Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 30.58% increase. The company also saw a substantial improvement in profitability, with a 530.06% increase in profit. The company's net worth Soared by an impressive increase of 25.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Cymbio Pharma had a public holding of 4.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹302,900,000.00
₹41,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Feb 2025 | State Bank Of India | ₹20.00 Cr | Open |
| 31 Mar 2021 | Others | ₹3.50 M | Open |
| 26 Jun 2014 | Others | ₹9.94 Cr | Open |
| 22 Apr 1999 | State Bank Of India | ₹2.05 Cr | Satisfied |
| 22 Apr 1999 | State Bank Of India | ₹2.05 Cr | Satisfied |
Explore comprehensive loan charge details -
Cymbio Pharma has a workforce of 34 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cymbio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cymbio Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with State Bank Of India amounted to Rs. 20.00 Cr with Charge ID 101051171 was registered on 04 Feb 2025. was documented.
A charge with Others of Rs. 9.94 Cr registered on 26 Jun 2014 with Charge ID 10509146 was modified on 31 Jul 2024. was recorded as a recent event.
Cymbio Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
Progress on Cymbio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore. was documented.
A charge with Others amounted to Rs. 0.35 Cr with Charge ID 100436699 was registered on 31 Mar 2021. was recorded as a recent event.
The activity A charge registered on 22 Apr 1999 via Charge ID 90200372 with State Bank Of India was fully satisfied on 04 Jul 2019. was completed.
The CIN of Cymbio Pharma Private Limited is U85110KA1998PTC024210.
Cymbio Pharma Private Limited is headquartered at No.23/4, Venkatala Yelahanka Hobli Yelahanka, Bangalore, Karnataka, 560064.
Cymbio Pharma Private Limited was incorporated on 14 September 1998.
The current directors of Cymbio Pharma Private Limited are
The primary industry of Cymbio Pharma Private Limited is Manufacturing.
Cymbio Pharma Private Limited is unlisted.
The authorized capital of Cymbio Pharma Private Limited is ₹10.00 Cr, and the paid-up capital is ₹2.50 Cr.
The compliance status of Cymbio Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX